P08913 ADA2A_HUMAN
Gene name: ADRA2A
Protein name: Alpha-2A adrenergic receptor
List of molecules and drugs that target protein P08913
# | DrugDomain Data | DrugBank Accession | Name | Drug action | Affinity data | InChI Key | SMILES |
---|---|---|---|---|---|---|---|
1 | P08913_DB00246 | DB00246 | Ziprasidone | antagonist | Ki(nM) = 154.0 | MVWVFYHBGMAFLY-UHFFFAOYSA-N | ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1 |
2 | P08913_DB00248 | DB00248 | Cabergoline | antagonist | KORNTPPJEAJQIU-KJXAQDMKSA-N | [H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC | |
3 | P08913_DB00320 | DB00320 | Dihydroergotamine | agonist | LUZRJRNZXALNLM-JGRZULCMSA-N | [H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O | |
4 | P08913_DB00321 | DB00321 | Amitriptyline | antagonist | Ki(nM) = 114.0 | KRMDCWKBEZIMAB-UHFFFAOYSA-N | CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12 |
5 | P08913_DB00363 | DB00363 | Clozapine | antagonist | Ki(nM) = 24.0 | QZUDBNBUXVUHMW-UHFFFAOYSA-N | CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=CC=CC=C12 |
6 | P08913_DB00368 | DB00368 | Norepinephrine | agonist | Ki(nM) = 30.0 EC50(nM) = 110.0 | SFLSHLFXELFNJZ-QMMMGPOBSA-N | NC[C@H](O)C1=CC(O)=C(O)C=C1 |
7 | P08913_DB00370 | DB00370 | Mirtazapine | antagonist | Ki(nM) = 20.0 IC50(nM) = 85.0 | RONZAEMNMFQXRA-UHFFFAOYSA-N | CN1CCN2C(C1)C1=CC=CC=C1CC1=C2N=CC=C1 |
8 | P08913_DB00408 | DB00408 | Loxapine | binder | Ki(nM) = 150.8 | XJGVXQDUIWGIRW-UHFFFAOYSA-N | CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2 |
9 | P08913_DB00413 | DB00413 | Pramipexole | agonist | Ki(nM) = 76.0 | FASDKYOPVNHBLU-ZETCQYMHSA-N | CCCN[C@H]1CCC2=C(C1)SC(N)=N2 |
10 | P08913_DB00449 | DB00449 | Dipivefrin | agonist | OCUJLLGVOUDECM-UHFFFAOYSA-N | CNCC(O)C1=CC(OC(=O)C(C)(C)C)=C(OC(=O)C(C)(C)C)C=C1 | |
11 | P08913_DB00457 | DB00457 | Prazosin | binder | Ki(nM) = 210.0 | IENZQIKPVFGBNW-UHFFFAOYSA-N | COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1=CC=CO1 |
12 | P08913_DB00484 | DB00484 | Brimonidine | agonist | Ki(nM) = 1.4 IC50(nM) = 3.0 EC50(nM) = 0.616595 | XYLJNLCSTIOKRM-UHFFFAOYSA-N | BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12 |
13 | P08913_DB00502 | DB00502 | Haloperidol | n/a | Ki(nM) = 600.0 | LNEPOXFFQSENCJ-UHFFFAOYSA-N | OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1 |
14 | P08913_DB00543 | DB00543 | Amoxapine | antagonist | QWGDMFLQWFTERH-UHFFFAOYSA-N | ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1 | |
15 | P08913_DB00555 | DB00555 | Lamotrigine | inhibitor | PYZRQGJRPPTADH-UHFFFAOYSA-N | NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1 | |
16 | P08913_DB00575 | DB00575 | Clonidine | agonist | GJSURZIOUXUGAL-UHFFFAOYSA-N | ClC1=CC=CC(Cl)=C1NC1=NCCN1 | |
17 | P08913_DB00589 | DB00589 | Lisuride | other/unknown | BKRGVLQUQGGVSM-KBXCAEBGSA-N | [H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC | |
18 | P08913_DB00629 | DB00629 | Guanabenz | agonist | Ki(nM) = 21.88 | WDZVGELJXXEGPV-YIXHJXPBSA-N | NC(N)=NN=CC1=C(Cl)C=CC=C1Cl |
19 | P08913_DB00633 | DB00633 | Dexmedetomidine | agonist | CUHVIMMYOGQXCV-NSHDSACASA-N | C[C@H](C1=CNC=N1)C1=C(C)C(C)=CC=C1 | |
20 | P08913_DB00656 | DB00656 | Trazodone | antagonist | Ki(nM) = 106.0 | PHLBKPHSAVXXEF-UHFFFAOYSA-N | ClC1=CC=CC(=C1)N1CCN(CCCN2N=C3C=CC=CN3C2=O)CC1 |
21 | P08913_DB00668 | DB00668 | Epinephrine | agonist | Ki(nM) = 5.0 IC50(nM) = 8.0 EC50(nM) = 30.0 | UCTWMZQNUQWSLP-VIFPVBQESA-N | CNC[C@H](O)C1=CC(O)=C(O)C=C1 |
22 | P08913_DB00692 | DB00692 | Phentolamine | antagonist | Ki(nM) = 1.58 | MRBDMNSDAVCSSF-UHFFFAOYSA-N | CC1=CC=C(C=C1)N(CC1=NCCN1)C1=CC(O)=CC=C1 |
23 | P08913_DB00696 | DB00696 | Ergotamine | partial agonist | XCGSFFUVFURLIX-VFGNJEKYSA-N | [H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O | |
24 | P08913_DB00714 | DB00714 | Apomorphine | agonist | Ki(nM) = 141.25 | VMWNQDUVQKEIOC-CYBMUJFWSA-N | [H][C@]12CC3=C(C(O)=C(O)C=C3)C3=CC=CC(CCN1C)=C23 |
25 | P08913_DB00726 | DB00726 | Trimipramine | antagonist | ZSCDBOWYZJWBIY-UHFFFAOYSA-N | CC(CN(C)C)CN1C2=CC=CC=C2CCC2=CC=CC=C12 | |
26 | P08913_DB00751 | DB00751 | Epinastine | unknown | WHWZLSFABNNENI-UHFFFAOYSA-N | NC1=NCC2N1C1=CC=CC=C1CC1=CC=CC=C21 | |
27 | P08913_DB00797 | DB00797 | Tolazoline | antagonist | Ki(nM) = 24.0 | JIVZKJJQOZQXQB-UHFFFAOYSA-N | C(C1=NCCN1)C1=CC=CC=C1 |
28 | P08913_DB00800 | DB00800 | Fenoldopam | antagonist | Ki(nM) = 16.0 | TVURRHSHRRELCG-UHFFFAOYSA-N | OC1=CC=C(C=C1)C1CNCCC2=C(Cl)C(O)=C(O)C=C12 |
29 | P08913_DB00852 | DB00852 | Pseudoephedrine | agonist | KWGRBVOPPLSCSI-WCBMZHEXSA-N | CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 | |
30 | P08913_DB00865 | DB00865 | Benzphetamine | agonist | YXKTVDFXDRQTKV-HNNXBMFYSA-N | C[C@@H](CC1=CC=CC=C1)N(C)CC1=CC=CC=C1 | |
31 | P08913_DB00925 | DB00925 | Phenoxybenzamine | antagonist | QZVCTJOXCFMACW-UHFFFAOYSA-N | CC(COC1=CC=CC=C1)N(CCCl)CC1=CC=CC=C1 | |
32 | P08913_DB00935 | DB00935 | Oxymetazoline | agonist | Ki(nM) = 0.79 EC50(nM) = 3.3 | WYWIFABBXFUGLM-UHFFFAOYSA-N | CC1=CC(=C(O)C(C)=C1CC1=NCCN1)C(C)(C)C |
33 | P08913_DB00964 | DB00964 | Apraclonidine | agonist | Ki(nM) = 7.94 | IEJXVRYNEISIKR-UHFFFAOYSA-N | NC1=CC(Cl)=C(NC2=NCCN2)C(Cl)=C1 |
34 | P08913_DB00968 | DB00968 | Methyldopa | agonist | CJCSPKMFHVPWAR-JTQLQIEISA-N | C[C@](N)(CC1=CC=C(O)C(O)=C1)C(O)=O | |
35 | P08913_DB01018 | DB01018 | Guanfacine | agonist | Ki(nM) = 50.3 | INJOMKTZOLKMBF-UHFFFAOYSA-N | NC(=N)NC(=O)CC1=C(Cl)C=CC=C1Cl |
36 | P08913_DB01136 | DB01136 | Carvedilol | antagonist | OGHNVEJMJSYVRP-UHFFFAOYSA-N | COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2 | |
37 | P08913_DB01149 | DB01149 | Nefazodone | antagonist | Ki(nM) = 84.0 | VRBKIVRKKCLPHA-UHFFFAOYSA-N | CCC1=NN(CCCN2CCN(CC2)C2=CC(Cl)=CC=C2)C(=O)N1CCOC1=CC=CC=C1 |
38 | P08913_DB01200 | DB01200 | Bromocriptine | agonist | Ki(nM) = 10.96 | OZVBMTJYIDMWIL-AYFBDAFISA-N | [H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=C(Br)NC6=CC=CC(=C56)C4=C3)(O[C@@]21O)C(C)C |
39 | P08913_DB01224 | DB01224 | Quetiapine | antagonist | Ki(nM) = 80.0 | URKOMYMAXPYINW-UHFFFAOYSA-N | OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12 |
40 | P08913_DB01238 | DB01238 | Aripiprazole | antagonist | Ki(nM) = 74.0 | CEUORZQYGODEFX-UHFFFAOYSA-N | ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl |
41 | P08913_DB01267 | DB01267 | Paliperidone | antagonist | Ki(nM) = 30.0 | PMXMIIMHBWHSKN-UHFFFAOYSA-N | CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1 |
42 | P08913_DB01392 | DB01392 | Yohimbine | antagonist | Ki(nM) = 0.32 IC50(nM) = 3.67 Kd(nM) = 2300.0 EC50(nM) = 8.5 | BLGXFZZNTVWLAY-SCYLSFHTSA-N | [H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=CC=CC=C31)C2 |
43 | P08913_DB01403 | DB01403 | Methotrimeprazine | antagonist | VRQVVMDWGGWHTJ-CQSZACIVSA-N | COC1=CC2=C(SC3=C(C=CC=C3)N2C[C@H](C)CN(C)C)C=C1 | |
44 | P08913_DB01472 | DB01472 | 4-Methoxyamphetamine | agonist | NEGYEDYHPHMHGK-UHFFFAOYSA-N | COC1=CC=C(CC(C)N)C=C1 | |
45 | P08913_DB01577 | DB01577 | Metamfetamine | agonist | MYWUZJCMWCOHBA-VIFPVBQESA-N | CN[C@@H](C)CC1=CC=CC=C1 | |
46 | P08913_DB01608 | DB01608 | Periciazine | antagonist | LUALIOATIOESLM-UHFFFAOYSA-N | OC1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C#N)CC1 | |
47 | P08913_DB01624 | DB01624 | Zuclopenthixol | antagonist | WFPIAZLQTJBIFN-DVZOWYKESA-N | OCCN1CCN(CC\C=C2\C3=C(SC4=C2C=C(Cl)C=C4)C=CC=C3)CC1 | |
48 | P08913_DB04846 | DB04846 | Celiprolol | antagonist | JOATXPAWOHTVSZ-UHFFFAOYSA-N | CCN(CC)C(=O)NC1=CC=C(OCC(O)CNC(C)(C)C)C(=C1)C(C)=O | |
49 | P08913_DB04855 | DB04855 | Dronedarone | antagonist | ZQTNQVWKHCQYLQ-UHFFFAOYSA-N | CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2 | |
50 | P08913_DB04948 | DB04948 | Lofexidine | agonist | Ki(nM) = 4.4 EC50(nM) = 6.3 | KSMAGQUYOIHWFS-UHFFFAOYSA-N | CC(OC1=C(Cl)C=CC=C1Cl)C1=NCCN1 |
51 | P08913_DB05492 | DB05492 | Epicept NP-1 | n/a | FKZUPMCBVURANR-UHFFFAOYSA-N | CC1=CC(=C(NCCCN)C=C1)[N+]([O-])=O | |
52 | P08913_DB06148 | DB06148 | Mianserin | antagonist | UEQUQVLFIPOEMF-UHFFFAOYSA-N | CN1CCN2C(C1)C1=CC=CC=C1CC1=CC=CC=C21 | |
53 | P08913_DB06153 | DB06153 | Pizotifen | antagonist | FIADGNVRKBPQEU-UHFFFAOYSA-N | CN1CCC(CC1)=C1C2=C(CCC3=CC=CC=C13)SC=C2 | |
54 | P08913_DB06216 | DB06216 | Asenapine | antagonist | Ki(nM) = 6.5 | VSWBSWWIRNCQIJ-UHFFFAOYSA-N | CN1CC2C(C1)C1=C(OC3=CC=C(Cl)C=C23)C=CC=C1 |
55 | P08913_DB06229 | DB06229 | Ocaperidone | n/a | ZZQNEJILGNNOEP-UHFFFAOYSA-N | CC1=CC=CN2C(=O)C(CCN3CCC(CC3)C3=NOC4=CC(F)=CC=C34)=C(C)N=C12 | |
56 | P08913_DB06262 | DB06262 | Droxidopa | agonist | QXWYKJLNLSIPIN-JGVFFNPUSA-N | N[C@@H]([C@H](O)C1=CC(O)=C(O)C=C1)C(O)=O | |
57 | P08913_DB06623 | DB06623 | Flupirtine | n/a | JUUFBMODXQKSTD-UHFFFAOYSA-N | CCOC(=O)NC1=C(N)N=C(NCC2=CC=C(F)C=C2)C=C1 | |
58 | P08913_DB06694 | DB06694 | Xylometazoline | agonist | Ki(nM) = 15.14 | HUCJFAOMUPXHDK-UHFFFAOYSA-N | CC1=CC(=CC(C)=C1CC1=NCCN1)C(C)(C)C |
59 | P08913_DB06711 | DB06711 | Naphazoline | agonist | Ki(nM) = 20.89 IC50(nM) = 0.0011 | CNIIGCLFLJGOGP-UHFFFAOYSA-N | C(C1=NCCN1)C1=CC=CC2=CC=CC=C12 |
60 | P08913_DB08815 | DB08815 | Lurasidone | n/a | PQXKDMSYBGKCJA-CVTJIBDQSA-N | [H][C@@]12[C@H]3CC[C@H](C3)[C@]1([H])C(=O)N(C[C@@H]1CCCC[C@H]1CN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O | |
61 | P08913_DB09242 | DB09242 | Moxonidine | agonist | WPNJAUFVNXKLIM-UHFFFAOYSA-N | COC1=NC(C)=NC(Cl)=C1NC1=NCCN1 | |
62 | P08913_DB09244 | DB09244 | Pirlindole | antagonist | IWVRVEIKCBFZNF-UHFFFAOYSA-N | CC1=CC=C2N3CCNC4CCCC(=C34)C2=C1 | |
63 | P08913_DB09286 | DB09286 | Pipamperone | antagonist | Ki(nM) = 860.0 | AXKPFOAXAHJUAG-UHFFFAOYSA-N | NC(=O)C1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)N1CCCCC1 |
64 | P08913_DB11278 | DB11278 | DL-Methylephedrine | agonist | FMCGSUUBYTWNDP-ONGXEEELSA-N | C[C@@H]([C@H](O)C1=CC=CC=C1)N(C)C | |
65 | P08913_DB11738 | DB11738 | Rilmenidine | n/a | CQXADFVORZEARL-UHFFFAOYSA-N | C1CC1C(NC1=NCCO1)C1CC1 | |
66 | P08913_DB14185 | DB14185 | Aripiprazole lauroxil | n/a | DDINXHAORAAYAD-UHFFFAOYSA-N | CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C3=C(Cl)C(Cl)=CC=C3)C=C12 |